A practicing primary care internist, the assistant vice president in the NYC Health + Hospitals Office of Ambulatory Care in New York City, and a clinical instructor at the Yale School of Medicine in New Haven, Connecticut.
A primary care physician and the director of innovation in clinic efficiency and cancer control at NYC Health + Hospitals in New York City.
AMA J Ethics. 2020 Feb 1;22(2):E147-155. doi: 10.1001/amajethics.2020.147.
Cancer continues to be a prominent cause of morbidity and mortality in low- and middle-income countries (LMICs). Many LMICs, however, lack adequate data to better understand and respond to trends in cancer incidence. This article highlights crucial roles that government and public-private coalitions can play in cancer surveillance in LMICs. In particular, local and global investment in LMICs can build essential structures for cancer prevention and early detection, including public health surveillance systems and cancer control coalitions. Using examples from LMICs that show the promises and pitfalls of these approaches, this article argues that comprehensive cancer control can motivate health equity.
癌症仍然是低收入和中等收入国家（LMICs）发病率和死亡率的主要原因。然而，许多 LMICs 缺乏足够的数据来更好地了解和应对癌症发病率的趋势。本文强调了政府和公私联盟在 LMICs 癌症监测中可以发挥的关键作用。特别是，对 LMICs 的当地和全球投资可以为癌症预防和早期发现建立必要的结构，包括公共卫生监测系统和癌症控制联盟。本文通过来自 LMICs 的例子，展示了这些方法的前景和陷阱，认为综合癌症控制可以促进健康公平。
